FBXO31 Polyklonaler Antikörper

FBXO31 Polyklonal Antikörper für WB, IHC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 27294-1-PBS

Synonyme

F box only protein 31, F box protein 31, F-box only protein 31, FBX14, FBX31

---

• 

  WB analysis of mouse brain using 27294-1-AP (same clone as 27294-1-PBS)

  mouse brain tissue were subjected to SDS PAGE followed by western blot with 27294-1-AP (FBXO31 Antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 27294-1-PBS in a different storage buffer formulation.

• 

  IHC staining of mouse uterus using 27294-1-AP (same clone as 27294-1-PBS)

  Immunohistochemical analysis of paraffin-embedded mouse uterus tissue slide using 27294-1-AP (FBXO31 antibody) at dilution of 1:1200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0). This data was developed using the same antibody clone with 27294-1-PBS in a different storage buffer formulation.

---

Geprüfte Anwendungen

Produktinformation

27294-1-PBS bindet in WB, IHC, Indirect ELISA FBXO31 und zeigt Reaktivität mit human, Maus

• Getestete Reaktivität: human, Maus
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: FBXO31 fusion protein Ag24867
• Vollständiger Name: F-box protein 31
• Beobachtetes Molekulargewicht: 49 kDa, 60-70 kDa
• GenBank-Zugangsnummer: BC012748
• Gene symbol: FBXO31
• Gene ID (NCBI): 79791
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS only
• Lagerungsbedingungen: Store at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

FBXO31, also known as F-box protein 31, is a substrate recognition protein of the SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex. It plays a crucial role in mediating the ubiquitination and subsequent degradation of target proteins through the ubiquitin-proteasome system. In pancreatic cancer, FBXO31 is upregulated and promotes cancer progression by targeting proteins like SIRT2 for degradation (PMID: 38216561). In endometrial cancer, FBXO31 acts as a tumor suppressor by regulating the ubiquitination of OGT (O-GlcNAc transferase), which affects cellular O-GlcNAcylation levels (PMID: 39894887). FBXO31 Is a reader of C-terminal amides, which ubiquitylates CTAPs for subsequent proteasomal degradation. A dominant de novo D334N mutation in FBXO31 alters FBXO31 substrate recognition and CTAP clearance, causing some important proteins to be degraded and clinical intellectual impairment or diplegic spastic cerebral (PMID: 39880951).